Oklo Inc (OKLO) Stock Price Today
Aura AI Summary
Key Stats
- $4.11BMarket Cap
- 12,655,079Volume
- UtilitiesSector
- $121.2352W High
- $22.1252W Low
- 38 DaysTypical Hold Time
- $1.65BEnterprise Value
- -Div Yield
- 38% Sell | 62% BuyTrading Activity
Track Oklo Inc (OKLO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Oklo Inc has traded between a low of $19.6 and a high of $121.23, highlighting its annual price range. Buy and sell Oklo Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Oklo Inc
Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Most Recent News
Hyperscalers invest hundreds of billions to boost AI data center accelerators amid rising demand.
Global tech giants like Amazon, Google, and Microsoft are committing hundreds of billions of dollars to expand AI-focused data center accelerators, driven by surging demand from generative AI workloads that exceed traditional CPU capabilities. These ...

Dune completes SOC 2 Type II, boosting trust as tokenized assets hit $32.6B amid growing institutional blockchain use.
Dune has completed a SOC 2 Type II examination with no exceptions, providing institutional clients with verified assurance of its data security standards. This milestone comes as tokenized real-world assets doubled to $32.6 billion and stablecoin mar...

Opus Genetics completes dosing in Phase 1/2 trial for gene therapy targeting inherited retinal diseases
Opus Genetics has finished dosing the higher-dose Cohort 2 in its Phase 1/2 trial of OPGx-BEST1, a gene therapy for BEST1-related inherited retinal diseases like Best vitelliform macular dystrophy and autosomal recessive bestrophinopathy. Cohort 2 en...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.